Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study

Neurourology and Urodynamics

Volumn 32, Issue 1, 2013, Pages 24-29

  Peters, Kenneth M ^a   Carrico, Donna J ^a   MacDiarmid, Scott A ^b   Wooldridge, Leslie S ^c   Khan, Ansar U ^d   McCoy, Craig E ^e   Franco, Nicholas ^f   Bennett, Jason B ^g  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Alliance Urology Specialists   (United States)

^c MERCY HEALTH PARTNERS   (United States)

^d Urology Health Center   (United States)

^e Central Missouri Women's Healthcare   (United States)

^f Specialists in Urology   (United States)

^g Female Pelvic Medicine and Urogynecology Institute of Michigan   (United States)

Author keywords

electric stimulation therapy; neuromodulation; nocturia; overactive; tibial nerve; urge; urinary bladder; urinary incontinence

Indexed keywords

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; NERVE STIMULATION; OVERACTIVE BLADDER; PATIENT SAFETY; PERCUTANEOUS TIBIAL NERVE STIMULATION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY FREQUENCY;

ADULT; AGED; AGED, 80 AND OVER; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIBIAL NERVE; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE;

EID: 84871364170     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22266     Document Type: Article

References (20)

1. Abrams P,. Describing bladder storage function: Overactive bladder syndrome and detrusor overactivity. Urology 2003; 62: 28-37; discussion 40-2. Epub 2003/12/10. (Pubitemid 37510015)
2. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36. (Pubitemid 44175300)
3. Nygaard I,. Clinical practice. Idiopathic urgency urinary incontinence. N Eng J Med 2010; 363: 1156-62. Epub 2010/09/17.
4. Chapple C, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis. Eur Urol 2005; 48: 5-26. Epub 2005/05/12. (Pubitemid 40835585)
5. Khullar V, Chapple C, Gabriel Z, et al. The effects of antimuscarinics on health-related quality of life in overactive bladder: A systematic review and meta-analysis. Urology 2006; 68: 38-48. Epub 2006/08/16. (Pubitemid 44189489)
6. Gopal M, Haynes K, Bellamy SL, et al. Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol 2008; 112: 1311-8.
7. Ridout AE, Yoong W,. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy. J Obstet Gynaecol 2010; 30: 111-4.
8. Herbison GP, Arnold EP,. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane database of systematic reviews (Online). 2009 (2):CD004202. Epub 2009/04/17.
9. Zinkgraf K, Quinn AO, Ketterhagen D, et al. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population. Urol Nurs 2009; 29: 30-4.
10. Finazzi-Agro E, Petta F, Sciobica F, et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: A randomized, double-blind, placebo controlled trial. J Urol 2010; 184: 2001-6.
11. Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: Results from the SUmiT Trial. J Urol 2010; 183: 1438-43.
12. Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: Results from the overactive bladder innovative therapy trial. J Urol 2009; 182: 1055-61.
13. MacDiarmid SA, Peters KM, Shobeiri SA, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 2010; 183: 234-40.
14. Chapple CR, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis. Eur Urol 2008; 54: 543-62. Epub 2008/07/05.
15. Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of Overactive Bladder in Women. Evidence Report/Technology Assessment No. 187 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I). AHRQ Publication No. 09-E017. Rockville, MD: Agency for Healthcare Research and Quality. August 2009.
16. Silow-Carroll S, Alteras T, Stepnick L,. Patient-centered care for underserved populations: Definition and best practices. Econ Soc Res Inst 2006; 1-43.
17. Ward-Smith P,. The cost of urinary incontinence. Urol Nurs 2009; 29: 188-90, 94. Epub 2009/07/08.
18. Cameron AP, Anger JT, Madison R, et al. National trends in the usage and success of sacral nerve test stimulation. J Urol 2011; 185: 970-5. Epub 2011/01/21.
19. Medicare. 42 Code of Federal Register. Hospital OPPs and CY 2011 Payment Rules. 2010.
20. Watanabe JH, Campbell JD, Ravelo A, et al. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology 2010; 76: 835-40.